Download
s13014-021-01904-4.pdf 1,23MB
WeightNameValue
1000 Titel
  • Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition
1000 Autor/in
  1. Guberina, Maja |
  2. Darwiche, Kaid |
  3. Hautzel, Hubertus |
  4. Pöttgen, Christoph |
  5. Guberina, Nika |
  6. Gauler, Thomas |
  7. Ploenes, Till |
  8. Umutlu, Lale |
  9. Theegarten, Dirk |
  10. Aigner, Clemens |
  11. Eberhardt, Wilfried E. E. |
  12. Metzenmacher, Martin |
  13. Wiesweg, Marcel |
  14. Karpf-Wissel, Rüdiger |
  15. Schuler, Martin |
  16. Herrmann, Ken |
  17. Stuschke, Martin |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-09-15
1000 Erschienen in
1000 Quellenangabe
  • 16(1):176
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s13014-021-01904-4 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442338/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Purpose!#!The aim of this study was to compare the pattern of intra-patient spread of lymph-node (LN)-metastases within the mediastinum as assessed by !##!Methods!#!This is a single-center study based on our preceding investigation, including all consecutive patients with initial diagnosis of stage IIIA-C NSCLC, receiving concurrent radiochemotherapy (12/2011-06/2018). Inclusion criteria were curative treatment intent, !##!Results!#!In total, 180 patients were enrolled. Various patterns of LN-spread could be identified. Skip lesions with an involved echelon distal from an uninvolved one were detected in less than 10% of patients by both EBUS-TBNA and PET. The pattern with largest asymmetry was detected in cases with EBUS-TBNA- or PET-positivity at all three echelons (p < 0.0001, exact symmetry test). In a multivariable logistic model for EBUS-positivity at echelon-3, prognostic factors were PET-positivity at echelon-3 (Hazard ratio (HR) = 12.1; 95%-CI: 3.2-46.5), EBUS-TBNA positivity at echelon-2 (HR = 6.7; 95%-CI: 1.31-31.2) and left-sided tumor location (HR = 4.0; 95%-CI: 1.24-13.2). There were significantly less combined ipsilateral upper (LN-stations 2 and 4) and lower (LN-station 7) mediastinal involvements (16.8% of patients) with EBUS-TBNA than with PET (38.9%, p < 0.0001, exact symmetry test). EBUS-TBNA detected a lobe specific heterogeneity between the odds ratios of LN-positivity in the upper versus lower mediastinum (p = 0.0021, Breslow-Day test), while PET did not (p = 0.19).!##!Conclusion!#!Frequent patterns of LN-metastatic spread could be defined by EBUS-TBNA and PET and discrepancies in the pattern were seen between both methods. EBUS-TBNA showed more lobe and tumor laterality specific patterns of LN-metastases than PET and skipped lymph node stations were rare. These systematic relations offer the opportunity to further refine multi-parameter risk of LN-involvement models for target volume delineation based on pattern of spread by EBUS-TBNA and PET.
1000 Sacherschließung
lokal Carcinoma, Non-Small-Cell Lung/diagnostic imaging [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Image-Guided Biopsy/methods [MeSH]
lokal Aged [MeSH]
lokal EBUS-TBNA
lokal Ultrasonography [MeSH]
lokal Pattern of spread
lokal Biopsy, Needle [MeSH]
lokal Fluorodeoxyglucose F18 [MeSH]
lokal Lymphatic Metastasis [MeSH]
lokal NSCLC
lokal Carcinoma, Non-Small-Cell Lung/radiotherapy [MeSH]
lokal Positron Emission Tomography Computed Tomography/methods [MeSH]
lokal Carcinoma, Non-Small-Cell Lung/pathology [MeSH]
lokal Lung Neoplasms/diagnostic imaging [MeSH]
lokal Adult [MeSH]
lokal Lung Neoplasms/radiotherapy [MeSH]
lokal Humans [MeSH]
lokal Clinical Radiation Oncology
lokal Middle Aged [MeSH]
lokal Lymphatic drainage
lokal Research
lokal Lung Neoplasms/pathology [MeSH]
lokal Radiation
lokal Radiotherapy, Image-Guided/methods [MeSH]
lokal Stage III
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-3218-0539|https://frl.publisso.de/adhoc/uri/RGFyd2ljaGUsIEthaWQ=|https://frl.publisso.de/adhoc/uri/SGF1dHplbCwgSHViZXJ0dXM=|https://frl.publisso.de/adhoc/uri/UMO2dHRnZW4sIENocmlzdG9waA==|https://frl.publisso.de/adhoc/uri/R3ViZXJpbmEsIE5pa2E=|https://frl.publisso.de/adhoc/uri/R2F1bGVyLCBUaG9tYXM=|https://frl.publisso.de/adhoc/uri/UGxvZW5lcywgVGlsbA==|https://frl.publisso.de/adhoc/uri/VW11dGx1LCBMYWxl|https://frl.publisso.de/adhoc/uri/VGhlZWdhcnRlbiwgRGlyaw==|https://frl.publisso.de/adhoc/uri/QWlnbmVyLCBDbGVtZW5z|https://frl.publisso.de/adhoc/uri/RWJlcmhhcmR0LCBXaWxmcmllZCBFLiBFLg==|https://frl.publisso.de/adhoc/uri/TWV0emVubWFjaGVyLCBNYXJ0aW4=|https://frl.publisso.de/adhoc/uri/V2llc3dlZywgTWFyY2Vs|https://frl.publisso.de/adhoc/uri/S2FycGYtV2lzc2VsLCBSw7xkaWdlcg==|https://frl.publisso.de/adhoc/uri/U2NodWxlciwgTWFydGlu|https://frl.publisso.de/adhoc/uri/SGVycm1hbm4sIEtlbg==|https://frl.publisso.de/adhoc/uri/U3R1c2Noa2UsIE1hcnRpbg==
1000 Hinweis
  • DeepGreen-ID: ddae8f1fd14c4ae583f577386f2814c4 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6463451.rdf
1000 Erstellt am 2023-11-15T18:42:59.421+0100
1000 Erstellt von 322
1000 beschreibt frl:6463451
1000 Zuletzt bearbeitet Thu Nov 30 21:41:41 CET 2023
1000 Objekt bearb. Thu Nov 30 21:41:41 CET 2023
1000 Vgl. frl:6463451
1000 Oai Id
  1. oai:frl.publisso.de:frl:6463451 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source